Puma Biotechnology Inc Cash Flow Reinvestment Rate

Latest as of December 2025: 1.88x

Puma Biotechnology Inc cash flow reinvestment rate. Puma Biotechnology Inc (PBYI) has a Cash Flow Reinvestment Rate of 1.88x as of December 2025, reinvesting $27.05 Million (capex $36.00K plus investments $-27.01 Million) from operating cash flow of $14.42 Million. See Puma Biotechnology Inc (PBYI) flexibility index to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

1.88x
(Capex + Investments) / Operating CF

Total Reinvested

$27.05 Million
Capex + Investments

Operating Cash Flow

$14.42 Million
USD

Capital Expenditures

$36.00K
USD

Cash Flow Reinvestment Rate of Puma Biotechnology Inc (2019–2025)

Cash flow reinvestment rate of Puma Biotechnology Inc from 2019 to 2025. Historical reinvestment intensity for Puma Biotechnology Inc across 6 annual periods. Explore debt repayment capacity of Puma Biotechnology Inc to assess how comfortably operating cash covers total debt obligations.

Puma Biotechnology Inc Cash Flow Reinvestment Rate by Year (2019–2025)

Puma Biotechnology Inc cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Puma Biotechnology Inc. For the full cash flow conversion analysis, see PBYI operating cash flow.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.87x $36.19 Million $41.80 Million $71.00K ▲ +64.4%
2024 0.53x $20.49 Million $38.92 Million $56.00K ▼ -59.9%
2023 1.31x $35.47 Million $27.01 Million $12.64 Million ▲ +149.2%
2021 0.53x $10.88 Million $20.65 Million $1.00K ▼ -99.3%
2020 79.37x $63.49 Million $800.00K $20.05 Million ▲ +30652.5%
2019 0.26x $5.78 Million $22.38 Million $306.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow